|
Acute phase response
|
HP_0033331 |
[Presence of one or more manifestations of the acute phase response. Acute phase proteins (APP) are blood proteins primarily synthesized by hepatocytes as part of the acute phase response (APR). The APR is part of the early-defense or innate immune system, which is triggered by different stimuli including trauma, infection, stress, neoplasia, and inflammation. The APR results in a complex systemic reaction with the goal of reestablishing homeostasis and promoting healing.] |
|
Abnormality of alkaline phosphatase level
|
HP_0004379 |
[An abnormality of alkaline phosphatase level.] |
|
Impaired neutrophil chemotaxis
|
HP_0040238 |
[An impairment of the migration of neutrophils towards chemoattractants as part of the innate immune response] |
|
Increased plasma vitamin K epoxide after vitamin K supplementation
|
HP_0040239 |
[Increased plasma vitamin K epoxide after vitamin K supplementation is present in VKCFD (vitamin K-dependent clotting factor deficiency) type 2, but not in VKCFD type 1.] |
|
Factor XIII subunit B deficiency
|
HP_0040234 |
[Deficiency of factor XIII subunit B, leading to a reduced factor XIII activity. Activated Factor XIII cross-links fibrin polymers solidifying the clot.] |
|
Leukocyte inclusion bodies
|
HP_0040235 |
[The presence of intraceullar inclusion bodies (aggregates of stainable substances, usually proteins) in leukocytes.] |
|
Neutrophil inclusion bodies
|
HP_0008264 |
[The presence of intracellular inclusion bodies (aggregates of stainable substances, usually proteins) in neutrophils. Cytoplasmic neutrophil inclusions (oval, basophilic) are also known as Doehle bodies.] |
|
organic polycyclic compound
|
CHEBI_51958 |
|
|
Hyperfibrinolysis
|
HP_0040236 |
[Increased degradation of fibrin, associated with clot instability and bleeding] |
|
Abnormality of fibrinolysis
|
HP_0040224 |
[Clinical phenotype characterized by delayed bleeding accelerated break down of blood clot (fibrinolysis)] |
|
17alpha-hydroxy steroid
|
CHEBI_35342 |
[The alpha-stereoisomer of 17-hydroxy steroid.] |
|
Impaired binding of factor VIII to VWF
|
HP_0040237 |
[Impaired binding of factor VIII to von Willebrand Factor. This is determined using a modified ELISA assay.] |
|
17beta-hydroxy steroid
|
CHEBI_35343 |
[A 17-hydroxy steroid in which the hydroxy group at position 17 has a beta-configuration.] |
|
11-hydroxy steroid
|
CHEBI_36841 |
|
|
3beta-hydroxy steroid
|
CHEBI_36836 |
[A 3-hydroxy steroid in which the 3-hydroxy substituent is in the beta-position.] |
|
Pruritis on hand
|
HP_0030899 |
[Pruritus is an itch or a sensation that makes a person want to scratch. This term refers to an abnormally increased sensation of itching over the skin of the hand.] |
|
organ specific developmental defect
|
MPATH_86 |
[Developmental defect characteristic of a particular organ or organ system which may be a recognised syndrome or a complex defect showing multiple manifestations.] |
|
Decreased intestinal transit time
|
HP_0030897 |
[A reduction in the length of time required for food to pass through the intestines.] |
|
Abnormal gastrointestinal transit time
|
HP_0030896 |
[A deviation from the normal amount of time required for food to pass through the intestines.] |
|
Pruritis on abdomen
|
HP_0030898 |
[Pruritus is an itch or a sensation that makes a person want to scratch. This term refers to an abnormally increased sensation of itching over the skin of the abdomen.] |